Projections of dependency and associated social care expenditure for the older population in England to 2038: effect of varying disability progression.


Journal

Age and ageing
ISSN: 1468-2834
Titre abrégé: Age Ageing
Pays: England
ID NLM: 0375655

Informations de publication

Date de publication:
01 07 2022
Historique:
received: 01 11 2021
revised: 20 04 2022
entrez: 24 7 2022
pubmed: 25 7 2022
medline: 27 7 2022
Statut: ppublish

Résumé

to assess the effect of recent stalling of life expectancy and various scenarios for disability progression on projections of social care expenditure between 2018 and 2038, and the likelihood of reaching the Ageing Society Grand Challenge mission of five extra healthy, independent years at birth. two linked projections models: the Population Ageing and Care Simulation (PACSim) model and the Care Policy and Evaluation Centre long-term care projections model, updated to include 2018-based population projections. PACSim: about 303,589 individuals aged 35 years and over (a 1% random sample of the England population in 2014) created from three nationally representative longitudinal ageing studies. Total social care expenditure (public and private) for older people, and men and women's independent life expectancy at age 65 (IndLE65) under five scenarios of changing disability progression and recovery with and without lower life expectancy. between 2018 and 2038, total care expenditure was projected to increase by 94.1%-1.25% of GDP; men's IndLE65 increasing by 14.7% (range 11.3-16.5%), exceeding the 8% equivalent of the increase in five healthy, independent years at birth, although women's IndLE65 increased by only 4.7% (range 3.2-5.8%). A 10% reduction in disability progression and increase in recovery resulted in the lowest increase in total care expenditure and increases in both men's and women's IndLE65 exceeding 8%. interventions that slow down disability progression, and improve recovery, could significantly reduce social care expenditure and meet government targets for increases in healthy, independent years.

Identifiants

pubmed: 35871421
pii: 6649132
doi: 10.1093/ageing/afac158
pmc: PMC9308990
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Références

J Econ Ageing. 2016 Dec;8:42-51
pubmed: 28580275
BMC Health Serv Res. 2009 Sep 24;9:172
pubmed: 19775476
Int J Geriatr Psychiatry. 2019 Jul;34(7):1095-1103
pubmed: 30950106
Br J Prev Soc Med. 1976 Jun;30(2):79-85
pubmed: 953380
BMC Med. 2019 Nov 12;17(1):201
pubmed: 31711480
PLoS One. 2021 Jan 21;16(1):e0245475
pubmed: 33476328
Age Ageing. 2018 Nov 1;47(6):764-768
pubmed: 30165372
Arch Intern Med. 2007 Apr 23;167(8):774-80
pubmed: 17452539
Lancet Public Health. 2017 May 23;2(7):e307-e313
pubmed: 28736759
Health Aff (Millwood). 2005;24 Suppl 2:W5R5-17
pubmed: 16186147
Health Soc Care Community. 2017 May;25(3):962-974
pubmed: 27709717
Arch Gerontol Geriatr. 2020 Jan - Feb;86:103931
pubmed: 31541858
Health Qual Life Outcomes. 2015 Oct 15;13:168
pubmed: 26467295
Age Ageing. 2018 May 01;47(3):374-380
pubmed: 29370339
Eur J Ageing. 2013 Jun 5;11(1):67-75
pubmed: 28804315
Lancet Reg Health Eur. 2021 Mar;2:100023
pubmed: 33870247
BMC Geriatr. 2012 Oct 16;12:63
pubmed: 23072476
Environ Health Prev Med. 2021 Jan 18;26(1):9
pubmed: 33461488
HSMHA Health Rep. 1971 Apr;86(4):347-54
pubmed: 5554262
Int J Epidemiol. 2021 Jul 9;50(3):841-851
pubmed: 33421052
Eur Respir Rev. 2020 Mar 20;29(155):
pubmed: 32198215
Can J Aging. 2014 Jun;33(2):208-19
pubmed: 24813722

Auteurs

Andrew Kingston (A)

Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Raphael Wittenberg (R)

Care Policy and Evaluation Centre (CPEC), London School of Economics and Political Science, London, UK.

Bo Hu (B)

Care Policy and Evaluation Centre (CPEC), London School of Economics and Political Science, London, UK.

Carol Jagger (C)

Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH